From an innocuous launch in the early 1980s, nebulizers have come a long way from being huge, noisy devices to portable handheld devices incorporating the latest technology. The global healthcare industry continues to witness widespread adoption of nebulizers as a go-to treatment option for asthma and COPD; primary demand drivers being a growing occurrence of chronic respiratory and related diseases coupled with swelling demand for and adoption of home healthcare products. In this context, the next-generation nebulizers market is anticipated to witness significant growth in the coming years.
Regionally, the nebulizers market is spread across North America, Latin America, Europe, Asia-Pacific, Japan and Middle East and Africa. The incidence of asthma and Chronic Obstructive Pulmonary Disease (COPD) is by far the highest in North America (COPD is the third major cause of death in the U.S), which is the primary reason for the region’s lion’s share in the nebulizers market.
Further, rising cases of respiratory illnesses and surgeries in the US is set to fuel North America’s next-generation nebulizers market. Asia Pacific has been hit hard by COPD, which is the seventh most common cause of death in Japan. Cases of asthma and COPD have increased tremendously in India and China. The growing number of patients requiring nebulization across the Asia Pacific has led to a sudden surge in demand for nebulizers.
The economic turmoil in 2008-09 proved beneficial for the nebulizers market as healthcare cost containment post the economic crisis compelled the US government to bring forth new plans to decrease patients’ stay in hospitals. In turn, this provided a conducive environment for the increased adoption of smart nebulizers in the region.
A sedentary lifestyle coupled with continuous technological advancements in the healthcare industry have pushed people to opt for at-home services, thereby bolstering the need for home healthcare devices. Undoubtedly, home healthcare services are a cost-effective, time saving and viable alternative for the treatment of several diseases.
The upsurge in respiratory diseases in the geriatric demography and austerity measures adopted by governments have propelled the demand for smart nebulizers. Rampant chronic respiratory diseases such as asthma, COPD, cystic fibrosis and bronchitis have aggravated the health of millions of people at a global level, thereby pushing the sales of smart nebulizers.
However, obstacles and challenges loom large in the nebulizers market. The availability of alternatives such as Metered-Dose-Inhaler (MDI) and use of oral medications have set daunting challenges to the growth in adoption of smart nebulizers. Further, research has unveiled that breathing techniques such as the Buteyko and Papworth methods may help alleviate asthma symptoms.
Plus, Yoga techniques such as pranayama possibly help boost the respiratory system. These factors are anticipated to threaten the growth of the smart nebulizers market in the near future.
Home nebulizers seem to make way for portable nebulizers that offer more convenience and ease of use to patients. Unlike home nebulizers, portable nebulizers run on batteries and can be easily used by patients without much intervention from healthcare professionals. Technological innovations in medical devices have benefited the smart nebulizers market and this trend is anticipated to continue into the future.
Prominent players in the global smart nebulizers market are launching newer products in the market to compete effectively with other players. A few of the key players include Koninklijke Philips N.V., Omron Corporation, PARI Pharma, Becton Dickinson & Company, and Briggs Healthcare.
In order to bolster their product portfolio and to effectively reach the target consumer base, companies in the nebulizers market are adopting strategies including mergers and acquisitions, collaborations, distribution agreements and patented product approvals to strengthen their business and promote cost and operational efficiencies.
This research publication on the next-generation nebulizers market delineates a comprehensive performance evaluation of the market on the global platform with the inclusion of historical data, valuable insights, facts, and figures.
The industry-validated and statistically supported data helps in acquiring a clearer picture of the current scenario while estimating future opportunities for revenue growth of the next-generation nebulizers market. This report on the smart nebulizers market includes projections that have been based on a suitable set of methodologies and assumptions and provides information and analysis according to the key market segments such as product type, modality and end-user.
The smart nebulizers market report is a collection of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. Besides, the report provides an in-depth analysis of parent market trends, indicators of macro-economic and governing factors along with market attractiveness of the various segments. The report also depicts the qualitative impact of various market factors on market segments and geographies.
Nebulizers can be categorized into the following subdivisions-based on product type, modality and end-user.
Next-generation Nebulizers Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
